Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus Patients

NCT06495281 · clinicaltrials.gov ↗
COMPLETED
Status
2044
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

LG Chem